University of Pittsburgh Cancer Institute (UPCI)

CCSG Acknowledgement

Required CCSG Acknowledgement

The NCI requires that publications acknowledge the UPCI CCSG support, and they are tracking compliance. If a UPCI CCSG-supported Shared Resource provided data used in your publication, please include the following statement in the acknowledgment section of your publication(s):

"This project used the UPCI [insert name(s) of shared resource(s)] that [is/are] supported in part by award P30CA047904."

Shared Resource Directors: Please make sure to include this statement on all of your order forms, contracts, etc. as a reminder to your users to acknowledge the UPCI CCSG support.


Overview

The Cancer Biomarkers Facility (CBF) provides UPCI researchers with direct access to genomic and proteomic services for the discovery and translation of molecular biomarkers that:

  1. advance the current understanding of disease
  2. drive the development of diagnostic tests; and
  3. enable the testing of new therapies in the clinic

The CBF is composed of multiple laboratories that support targeted and systems-level investigations of cancer biology with fully integrated bioinformatics and data analysis/interpretation support. Drs. William LaFramboise and Nathan Yates co-direct the CBF, and are supported by a high performance team of experts that develop and apply rapidly evolving technologies. Click below to learn more about our services and equipment.

Genomics Services: DNA

Extraction and QA/QC Genotyping Sequencing

Genomics Services: RNA

Extraction and QA/QC Expression Sequencing

Proteomics Services: Mass Spectrometry

Protein Identification Targeted Proteomics Discovery Proteomics

Proteomics Services: Immunoassays

Luminex Auson SearchLight